Search Results

Displaying Results 1-1 of 1 "'BBIO'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money

May 12, 2026, 08:30 ET Wall Street's Cardiac Bet: Where Diagnostics Meet the Money

backlogs[2]. Five companies sit at the center of this convergence: VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF), BridgeBio Pharma (NASDAQ: BBIO), Bristol Myers Squibb (NYSE: BMY), Arrowhead Pharmaceuticals (NASDAQ: ARWR), and Amgen (NASDAQ: AMGN). 

More news about: USA News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.